3ZH-26707-45182
2 vaccinations
4 coded responses
25 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 194 / PA
- Registered
- 2021-04-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-27
Registered in v-safe
-
2021-04-27
Dose 1 — Pfizer-BioNTech
- 2021-04-27
- 2021-04-28
- 2021-04-29
- 2021-04-30
- 2021-05-01
- 2021-05-02
- 2021-05-03
- 2021-05-04
- 2021-05-11
-
2021-05-18
Dose 2 — Pfizer-BioNTech
- 2021-05-18
-
2021-05-19
Survey response — days 1–6 daily, dose 2MedDRA: Diarrhoea — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to workFree text: Loose stoolMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-20
Survey response — days 1–6 daily, dose 2MedDRA: Hyperhidrosis — Feeling: Good · Site: Pain · Fever · Fatigue or tirednessFree text: SweatyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-21
Survey response — days 1–6 daily, dose 2MedDRA: Decreased appetite — Feeling: Good · Site: PainFree text: Loss of appetiteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-22
- 2021-05-23
- 2021-05-24
- 2021-05-25
- 2021-06-01
- 2021-06-08
- 2021-06-15
- 2021-06-22
- 2021-06-29
- 2021-08-17
- 2021-11-16
-
2022-05-18
Survey response — 12 months, dose 2MedDRA: Sinusitis — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Sinus infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-05-18
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-05-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-27 | Pfizer-BioNTech | |
| 2 | 2021-05-18 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-05-18 | Unsuccessful |
Free text
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Loose stool
Systemic reaction (other): Sweaty
Systemic reaction (other): Loss of appetite
Release 11 — 12 months, dose 2
Symptoms: Sinus infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Sinusitis | · | · | ✓ |
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
| SRO | Diarrhoea | ✓ | ✓ | ✓ |
| SRO | Hyperhidrosis | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release